Overall, our findings provide new insight regarding the protective mechanisms used by circulating memory CD8+ T cells during a secondary viral infection in peripheral tissues, but also reveals important information about how “prime-boost” vaccination strategies of generating circulating memory CD8+ T cells followed by a local heterologous challenge will generate antigen-specific secondary memory T cell populations in non-lymphoid tissues such as the skin. This evidence concerns the gene CD8A and viral infectious disease.